XTX Topco’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

XTX Topco’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-29,016	Closed	-$456K	–	2629
2024 Q1	$456K	Buy	+29,016	New	+$447K	0.06%	548
2023 Q4	–	Sell	-25,628	Closed	-$326K	–	2280
2023 Q3	$326K	Buy	+25,628	New	+$354K	0.06%	668
2022 Q4	–	Sell	-22,735	Closed	-$421K	–	1590
2022 Q3	$421K	Buy	+22,735	New	+$357K	0.1%	314
2022 Q1	–	Sell	-24,403	Closed	-$238K	–	1011
2021 Q4	$238K	Buy	+24,403	New	+$459K	0.13%	298

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

XTX Topco's DCPH Position: Q2 2024 in Review

XTX Topco sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 29,016 shares — an estimated $456K sold.

XTX Topco first reported a position in DCPH in Q4 2021 and held it in 4 quarters. The position peaked at $456K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

XTX Topco reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 29,016 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $456K.
XTX Topco first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
XTX Topco's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $456K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.